238 related articles for article (PubMed ID: 2544002)
1. The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness.
Amsterdam JD; Maislin G; Gold P; Winokur A
Psychoneuroendocrinology; 1989; 14(1-2):43-62. PubMed ID: 2544002
[TBL] [Abstract][Full Text] [Related]
2. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
Amsterdam JD; Maislin G; Winokur A; Kling M; Gold P
Arch Gen Psychiatry; 1987 Sep; 44(9):775-81. PubMed ID: 2820340
[TBL] [Abstract][Full Text] [Related]
3. The oCRH stimulation test before and after clinical recovery from depression.
Amsterdam JD; Maislin G; Winokur A; Berwish N; Kling M; Gold P
J Affect Disord; 1988; 14(3):213-22. PubMed ID: 2838538
[TBL] [Abstract][Full Text] [Related]
4. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
Twardowska K; Rybakowski J
Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Scott LV; Dinan TG
Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
[TBL] [Abstract][Full Text] [Related]
6. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
[TBL] [Abstract][Full Text] [Related]
7. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
8. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
9. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
Sher L
ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
[TBL] [Abstract][Full Text] [Related]
10. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
[TBL] [Abstract][Full Text] [Related]
11. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
15. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
16. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
[TBL] [Abstract][Full Text] [Related]
17. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
Wirtz PH; Siegrist J; Schuhmacher A; Hoefels S; Maier W; Zobel AW
Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
[TBL] [Abstract][Full Text] [Related]
18. The hypothalamic-pituitary-adrenal axis in depression.
Meltzer HY; Lowy MT; Koenig JI
Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
[No Abstract] [Full Text] [Related]
19. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
20. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
Schinke C; Hesse S; Stoppe M; Meyer K; Schmidt E; Orthgiess J; Bechmann L; Bresch A; Rullmann M; Luthardt J; Sabri O; Blüher M; Kratzsch J; Then Bergh F
Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
